Trials / Completed
CompletedNCT04686825
The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects
A Randomized, Open-label, Single-dose, 4-way Crossover Phase 1 Study to Evaluate the Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, open-label, single-dose, 4-way crossover phase 1 study to evaluate the food effect on pharmacokinetics of DA-8010 after a single administration of DA-8010 2.5 mg or 5 mg under fasting and fed states in healthy male and female subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-8010 2.5mg (Fasting) | Test drug l : DA-8010 2.5mg (Fasting) |
| DRUG | DA-8010 2.5mg (Fed) | Test drug ll : DA-8010 2.5mg (Fed) |
| DRUG | DA-8010 5mg (Fasting) | Test drug llI : DA-8010 5mg (Fasting) |
| DRUG | DA-8010 5mg (Fed) | Test drug lV : DA-8010 5mg (Fed) |
Timeline
- Start date
- 2021-01-13
- Primary completion
- 2021-02-17
- Completion
- 2021-03-11
- First posted
- 2020-12-29
- Last updated
- 2021-05-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04686825. Inclusion in this directory is not an endorsement.